3 results match your criteria: "CHUQ Research Centre (CHUL)[Affiliation]"
Cell Transplant
June 2013
Neurosciences Division-Human Genetics, CHUQ Research Centre-CHUL, Quebec, Canada.
Cell therapies consist in transplanting healthy cells into a disabled tissue with the goal to repopulate it and restore its function at least partially. In muscular diseases, most of the time, myoblasts are chosen for their expansion capacity in culture. Nevertheless, cell transplantation has limitations, among them, death of the transplanted cells, during the days following the graft.
View Article and Find Full Text PDFCell Transplant
August 2012
Neurosciences Division-Human Genetics, CHUQ Research Centre-CHUL, Quebec, Canada.
Duchenne muscular dystrophy (DMD) is the most frequent muscular dystrophy in children and young adults. Currently, there is no cure for the disease. The transplantation of healthy myoblasts is an experimental therapeutic strategy, since it could restore the expression of dystrophin in DMD muscles.
View Article and Find Full Text PDFBMC Dev Biol
February 2008
Ontogeny-Reproduction Research Unit, CHUQ Research Centre (CHUL), Québec City, Québec, Canada.
Background: Homeoproteins are a class of transcription factors that are well-known regulators of organogenesis and cell differentiation in numerous tissues, including the male reproductive system. Indeed, a handful of homeoproteins have so far been identified in the testis and epididymis where a few were shown to play important developmental roles. Through a degenerate PCR approach aimed at identifying novel homeoproteins expressed in the male reproductive system, we have detected several homeoproteins most of which had never been described before in this tissue.
View Article and Find Full Text PDF